{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:18:58Z","timestamp":1788437938231,"version":"build-2803163510"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>CONTEXT:<\/jats:title>\n                    <jats:p>Multiple sclerosis (MS) is the most common demyelinating disease of the central nervous system, where demyelination occurs alongside axonal and neuronal degeneration. Current treatments focus primarily on immunomodulation and symptom management, with limited efficacy in halting or reversing demyelination. Finding drugs to treat progression of the disease remains the greatest unmet need for people with MS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MATERIALS AND METHODS:<\/jats:title>\n                    <jats:p>Demyelination is induced in Swiss albino mice by administering cuprizone (CPZ) 0.3% in the diet for 6 weeks. Two different doses (1.2 and 2.4 mg\/kg) of flunarizine dihydrochloride were administered orally along with CPZ for a duration of six weeks. We used the rotarod apparatus and actophotometer to assess motor and locomotor activity, elevated plus maze to evaluate anxiety, and shuttle box apparatus to evaluate memory. Various biochemical parameters were estimated from brain homogenate, and the histological changes were evaluated using H and E and Luxol Fast Blue stain. The experimental data obtained were analysed by ANOVA followed by the Tukey multiple comparison test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>The result of behavioural assays showed better motor coordination, locomotion, memory, and reduced anxiety levels in the drug-treated mice. Besides, the elevated level of serotonin and the reduced levels of glutamate and catalase level in the brain homogenate of treated mice indicate its neuroprotective potential. Healthy histology appearance and increased level of myelin in the brain also substantiate the protective effect of Flunarizine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Our experimental data suggest that flunarizine dihydrochloride attenuated the demyelination in the brain and also produced functional and behavioural improvement in demyelinated mice, suggesting its potential to manage demyelinating disorders.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijp.ijp_1266_25","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:01:03Z","timestamp":1788354063000},"page":"581-590","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Flunarizine prevents demyelination and neurological deficits in a cuprizone-induced mouse model of multiple sclerosis"],"prefix":"10.4103","volume":"58","author":[{"given":"Gopika","family":"Venu","sequence":"first","affiliation":[{"name":"Department of Pharmacology, College of Pharmaceutical Sciences, Government Medical College, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. S. Binil","family":"Raj","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, College of Pharmaceutical Sciences, Government Medical College, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"R1-20260903","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1474-4422(19)30411-9","article-title":"The global burden of neurological disorders: Translating evidence into policy","volume":"19","author":"Feigin","year":"2020","journal-title":"Lancet Neurol"},{"key":"R2-20260903","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/jcp.2005.031195","article-title":"Demyelinating diseases","volume":"59","author":"Love","year":"2006","journal-title":"J Clin Pathol"},{"key":"R4-20260903","first-page":"1","article-title":"Multiple sclerosis: Pathogenesis, symptoms, diagnoses and cell-based therapy","volume":"19","author":"Ghasemi","year":"2017","journal-title":"Cell J"},{"key":"R5-20260903","doi-asserted-by":"crossref","first-page":"102261","DOI":"10.1016\/j.msard.2020.102261","article-title":"Anxiety and depression in multiple sclerosis (MS): Antecedents, consequences, and differential impact on well-being and quality of life","volume":"44","author":"Hanna","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"R6-20260903","first-page":"e11293","article-title":"Multiple sclerosis and serotonin: Potential therapeutic applications","volume":"12","author":"San Hernandez","year":"2020","journal-title":"Cureus"},{"key":"R7-20260903","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2015.11.010","article-title":"Oxidative stress in multiple sclerosis: Central and peripheral mode of action","volume":"277","author":"Ohl","year":"2016","journal-title":"Exp Neurol"},{"key":"R8-20260903","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/jnnp-2020-324286","article-title":"Systematic approach to selecting licensed drugs for repurposing in the treatment of progressive multiple sclerosis","volume":"92","author":"Cunniffe","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R9-20260903","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41572-018-0041-4","article-title":"Multiple sclerosis","volume":"4","author":"Filippi","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"suppl 446","key":"R10-20260903","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/00016488709121858","article-title":"Effect of flunarizine on experimentally induced facial nerve injury","volume":"104","author":"Takimoto","year":"1987","journal-title":"Acta Otolaryngol"},{"key":"R11-20260903","article-title":"Flunarizine 5 mg daily alters disability in progressive multiple sclerosis: 2 cases [Internet]","author":"DeFreitas","journal-title":"2021.Available from:"},{"key":"R12-20260903","first-page":"283","article-title":"Radical scavenging action of flunarizine in rat brain in vitro","volume":"272","author":"Kubo","year":"1984","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"R14-20260903","article-title":"Histological and Histochemical Techniques","author":"Kieman","year":"1999"},{"key":"R15-20260903","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/jemt.1057","article-title":"Axonal degeneration is an early pathological feature in autoimmune-mediated demyelination in mice","volume":"52","author":"Onuki","year":"2001","journal-title":"Microsc Res Tech"},{"key":"R16-20260903","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","article-title":"Multiple sclerosis: Experimental models and reality","volume":"133","author":"Lassmann","year":"2017","journal-title":"Acta Neuropathol"},{"key":"R17-20260903","article-title":"Hand Book of Experimental Pharmacology","author":"Kulkarni","year":"1987","journal-title":"Vallabh Prakashan, New Delhi, India"},{"key":"R18-20260903","first-page":"714","article-title":"Skeletal muscle relaxant property of diazepam by using rotarod on albino mice","volume":"4","author":"Veena","year":"2015","journal-title":"Indian J Basic Appl Med Res"},{"key":"R19-20260903","first-page":"403","article-title":"The central nervous system activity of Barleria prionitis Linn. on the locomotor activity of Swiss albino mice using actophotometer","volume":"3","author":"Gangopadhyay","year":"2012","journal-title":"Int J Pharm Biol Arch"},{"key":"R20-20260903","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0149-7634(96)00058-9","article-title":"Anxiety, defence and the elevated plus-maze","volume":"21","author":"Rodgers","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"R21-20260903","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jep.2016.10.011","article-title":"Beneficial effect of commercial Rhodiola extract in rats with scopolamine-induced memory impairment on active avoidance","volume":"193","author":"Vasileva","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"R22-20260903","first-page":"188","article-title":"Consequences of glutamatergic and GABAergic neurotransmitter changes aggravating the complications of ethanol withdrawal can be challenged by administration of extract of Zingiber officinale","volume":"4","author":"Marella","year":"2012","journal-title":"J Toxicol Sci"},{"key":"R23-20260903","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1016\/0006-2952(74)90235-4","article-title":"A fluorometric micromethod for the simultaneous determination of serotonin, noradrenaline and dopamine in milligram amounts of brain tissue","volume":"23","author":"Schlumpf","year":"1974","journal-title":"Biochem Pharmacol"},{"key":"R24-20260903","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0003-2697(79)90738-3","article-title":"Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction","volume":"95","author":"Ohkawa","year":"1979","journal-title":"Anal Biochem"},{"key":"R25-20260903","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.yebeh.2012.11.004","article-title":"Effect of saponin fraction from Ficus religiosa on memory deficit, and behavioral and biochemical impairments in pentylenetetrazol kindled mice","volume":"27","author":"Singh","year":"2013","journal-title":"Epilepsy Behav"},{"key":"R26-20260903","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.fct.2010.01.016","article-title":"Antioxidant potential of tea reduces arsenite induced oxidative stress in Swiss albino mice","volume":"48","author":"Sinha","year":"2010","journal-title":"Food Chem Toxicol"},{"key":"R27-20260903","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0076-6879(84)05016-3","article-title":"Catalase in vitro","volume":"105","author":"Aebi","year":"1984","journal-title":"Methods Enzymol"},{"key":"R28-20260903","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4103\/1673-5374.189184","article-title":"Calcium channel inhibition-mediated axonal stabilization improves axonal regeneration after optic nerve crush","volume":"11","author":"Ribas","year":"2016","journal-title":"Neural Regen Res"},{"key":"R29-20260903","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12974-022-02476-0","article-title":"Network alterations underlying anxiety symptoms in early multiple sclerosis","volume":"19","author":"Ellwardt","year":"2022","journal-title":"J Neuroinflammation"},{"key":"R30-20260903","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuron.2008.01.004","article-title":"Calcium channel modulation as an all-purpose mechanism for short-term synaptic plasticity","volume":"57","author":"Cheng","year":"2008","journal-title":"Neuron"},{"key":"R31-20260903","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.neulet.2008.11.058","article-title":"Demyelination of the hippocampus is prominent in the cuprizone model","volume":"451","author":"Koutsoudaki","year":"2009","journal-title":"Neurosci Lett"},{"key":"R32-20260903","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5213\/inj.2011.15.3.127","article-title":"Exploring the potential of flunarizine for cisplatin-induced painful uremic neuropathy in rats","volume":"15","author":"Muthuraman","year":"2011","journal-title":"Int Neurourol J"}],"container-title":["Indian Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_1266_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:03:19Z","timestamp":1788436999000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijp.ijp_1266_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijp.ijp_1266_25","relation":{},"ISSN":["0253-7613","1998-3751"],"issn-type":[{"value":"0253-7613","type":"print"},{"value":"1998-3751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2025-12-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}